Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland)
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4401
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). 4401
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018
The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
The up-regulation of cysteinyl-leukotriene receptors on T cells Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003
5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of human dendritic cells Source: Annual Congress 2009 - Airway cell biology Year: 2009
Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2) Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
AMP affects intracellular Ca2+ signalling, migration, cytokine secretion and T-cell priming capacity of human dendritic cells Source: Annual Congress 2009 - Airway cell biology Year: 2009
Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Central role for phosphoinositide-3-kinase gamma/delta dependent signalling in eosinophilic pulmonary inflammation driven by innate lymphoid cells Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017
Toll-like receptors in human T lymphocytes: altered expression during tonsillar inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 223s Year: 2005
Differential toll-like receptor (TLR) responses of primary human alveolar macrophages and type II epithelial (AT2) cells alone and in co-culture Source: Annual Congress 2009 - Epithelial cell biology Year: 2009
GB001 potently inhibits PGD2 metabolite-induced DP2-mediated cell signaling and eosinophil activation Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages Source: Eur Respir J 2007; 29: 986-994 Year: 2007
Human CD40 ligand-expressing type 3 innate lymphoid cells induce interleukin (IL)-10-producing immature transitional regulatory B-cells Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018
The muscarinic receptors promote IL-8 release in airway epithelial cells via the pERK42/44 and NF-kB pathways Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006
Tc1 cells increase after allergen stimulation and inhibit Th2 cell activation: a case study Source: Eur Respir J 2001; 18: Suppl. 33, 273s Year: 2001